Abstract. Cell surface heparan sulfate (HS) proteoglycans interact with other extracellular matrix (ECM) components, and HS-binding regions are present in ECM proteins such as fibronectin and fibrillin. Because of their previously established role in susceptibility to intracranial aneurysms, the authors sought to determine whether polymorphisms of fibronectin (FN1, rs2289202) and fibrillin 2 (FBN2, rs331069) associate with selected cardiovascular risk factors and events in the TAMRISK study. A 50-year-old Finnish cohort of 810 subjects of whom 340 had diagnosed hypertension was analyzed. Samples were genotyped for FN1 rs2289202 and FBN2 rs331069 polymorphisms. Incidence of myocardial infarction (I21-I22), transient cerebral ischemic attacks (TIA, G45) and cerebrovascular diseases (I60-I69) were followed up until the subjects were on the average 60 years old. Subjects with FN1 rs2289202 (G>A) minor genotype AA had significantly more cerebrovascular disease than those with the G allele [P<0.001, odds ratio (OR), 8.73; confidence index (CI), 2.79-27.31], although those with the A allele had lower body mass index (P= 0.008). Subjects with fibrillin rs331069 (T>C) minor genotype CC had more atherothrombotic disease (P=0.012, OR, 3.16; CI, 1.29-7.71), as measured by combined myocardial infarction and TIA, than those with the T allele. The gene polymorphisms for fibronectin and fibrillin 2 appear to associate with vascular disease.
IntroductionThe extracellular matrix (ECM) consists of a network of proteins, glycoproteins, and proteoglycans. Mutations in genes coding for ECM are known to lead to numerous diseases (1).Heparan sulfate (HS) glycosaminoglycan chains are components of HS proteoglycans (HSPG) that mediate interactions between the cell and the ECM. HS chains mediate signaling by binding a multitude of growth factors, but also cell adhesion proteins such as fibronectin and fibrillin 2, which are unique in having cell surface integrin-and HS-binding regions (2). An alteration in cross talk between ECM and cells is most likely linked to development of diseases (1).Fibronectin is a major glycoprotein component of the ECM. It plays an important part in cell adhesion, migration and differentiation (3). The single pre-mRNA is alternatively spliced, and fibronectin has at least 20 different isoforms in humans (4). Fibronectin is upregulated in atherosclerosis (5). Mutations in the fibronectin gene are known to be associated with human glomerulopathy (6). Fibrillin 2 is a widely distributed major component of extracellular microfibrils throughout the body. Mutations in the fibrillin 2 (FBN2) gene cause congenital contractural arachnodactyly (CCA), which is phenotypically similar to the Marfan syndrome (MFS) (7). However, in contrast to MFS, CCA does not affect the aorta or the eyes. All the identified disease-causing mutations in FBN2 cluster in a limited region between exons 23 and 34 (8).The authors have previously observed in the present study population an association between the HSPG gene syndecan-4 SNP rs1981429...